119 related articles for article (PubMed ID: 10084694)
21. Targeting of T lymphocytes against EGF-receptor+ tumor cells by bispecific monoclonal antibodies: requirement of CD3 molecule cross-linking for T-cell activation.
Ferrini S; Cambiaggi A; Sforzini S; Marciano S; Canevari S; Mezzanzanica D; Colnaghi MI; Grossi CE; Moretta L
Int J Cancer; 1993 Dec; 55(6):931-7. PubMed ID: 8253530
[TBL] [Abstract][Full Text] [Related]
22. CD24 targeting bi-specific antibody that simultaneously stimulates NKG2D enhances the efficacy of cancer immunotherapy.
Han Y; Sun F; Zhang X; Wang T; Jiang J; Cai J; Gao Q; Hezam K; Liu Y; Xie J; Wang M; Zhang J
J Cancer Res Clin Oncol; 2019 May; 145(5):1179-1190. PubMed ID: 30778749
[TBL] [Abstract][Full Text] [Related]
23. T cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model. II. Syngeneic colon carcinoma CC531 is efficiently killed by retargeted cytotoxic T lymphocytes in vitro despite limited lysis in 51Cr release assays.
Beun GD; Gorter A; Nooyen Y; van de Velde CJ; Fleuren GJ
J Immunol; 1993 Mar; 150(6):2305-15. PubMed ID: 8450213
[TBL] [Abstract][Full Text] [Related]
24. NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium.
Ryan JC; Niemi EC; Goldfien RD; Hiserodt JC; Seaman WE
J Immunol; 1991 Nov; 147(9):3244-50. PubMed ID: 1919012
[TBL] [Abstract][Full Text] [Related]
25. Characterization and comparison of the lytic function of NKR-P1+ and NKR-P1-rat natural killer cell clones established from NKR-P1bright/TCR alpha beta-cell lines.
Brissette-Storkus C; Appasamy PM; Hayes LA; Kaufman CL; Ildstad ST; Chambers WH
Nat Immun; 1995; 14(2):98-113. PubMed ID: 8601077
[TBL] [Abstract][Full Text] [Related]
26. Expression of a soluble transforming growth factor-beta (TGFbeta) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcoma in vivo.
Witham TF; Villa L; Yang T; Pollack IF; Okada H; Robbins PD; Chambers WH
J Neurooncol; 2003; 64(1-2):63-9. PubMed ID: 12952287
[TBL] [Abstract][Full Text] [Related]
27. The NKR-P1B gene product is an inhibitory receptor on SJL/J NK cells.
Kung SK; Su RC; Shannon J; Miller RG
J Immunol; 1999 May; 162(10):5876-87. PubMed ID: 10229823
[TBL] [Abstract][Full Text] [Related]
28. Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12.
Bennett IM; Zatsepina O; Zamai L; Azzoni L; Mikheeva T; Perussia B
J Exp Med; 1996 Nov; 184(5):1845-56. PubMed ID: 8920872
[TBL] [Abstract][Full Text] [Related]
29. Natural killer cell proliferation induced by anti-NK1.1 and IL-2.
Reichlin A; Yokoyama WM
Immunol Cell Biol; 1998 Apr; 76(2):143-52. PubMed ID: 9619484
[TBL] [Abstract][Full Text] [Related]
30. Production and characterization of a novel monoclonal antibody inhibitory for murine natural killer cell activity.
Hoskin DW; Roder JC
Immunol Invest; 1992 Feb; 21(1):11-23. PubMed ID: 1548044
[TBL] [Abstract][Full Text] [Related]
31. CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V alpha 24 J alpha Q T cell receptor alpha chains.
Exley M; Porcelli S; Furman M; Garcia J; Balk S
J Exp Med; 1998 Sep; 188(5):867-76. PubMed ID: 9730888
[TBL] [Abstract][Full Text] [Related]
32. CD8(+)NKR-P1A (+)T cells preferentially accumulate in human liver.
Ishihara S; Nieda M; Kitayama J; Osada T; Yabe T; Ishikawa Y; Nagawa H; Muto T; Juji T
Eur J Immunol; 1999 Aug; 29(8):2406-13. PubMed ID: 10458753
[TBL] [Abstract][Full Text] [Related]
33. CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphoma.
Pohl C; Denfeld R; Renner C; Jung W; Bohlen H; Sahin U; Hombach A; van Lier R; Schwonzen M; Diehl V
Int J Cancer; 1993 Jul; 54(5):820-7. PubMed ID: 7686889
[TBL] [Abstract][Full Text] [Related]
34. The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma.
Rothe A; Jachimowicz RD; Borchmann S; Madlener M; Keßler J; Reiners KS; Sauer M; Hansen HP; Ullrich RT; Chatterjee S; Borchmann P; Yazaki P; Koslowsky TC; Engert A; Heukamp LC; Hallek M; von Strandmann EP
Int J Cancer; 2014 Jun; 134(12):2829-40. PubMed ID: 24242212
[TBL] [Abstract][Full Text] [Related]
35. HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity.
Peipp M; Derer S; Lohse S; Staudinger M; Klausz K; Valerius T; Gramatzki M; Kellner C
Oncotarget; 2015 Oct; 6(31):32075-88. PubMed ID: 26392331
[TBL] [Abstract][Full Text] [Related]
36. Drug resistance in rat colon cancer cell lines is associated with minor changes in susceptibility to cytotoxic cells.
Van de Vrie W; Van der Heyden SA; Gheuens EE; Bijma AM; De Bruijn EA; Marquet RL; Van Oosterom AT; Eggermont AM
Cancer Immunol Immunother; 1993 Oct; 37(5):337-42. PubMed ID: 8402737
[TBL] [Abstract][Full Text] [Related]
37. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody.
Aramburu J; Balboa MA; Izquierdo M; López-Botet M
J Immunol; 1991 Jul; 147(2):714-21. PubMed ID: 1830071
[TBL] [Abstract][Full Text] [Related]
38. Rat interleukin-2-activated natural killer (A-NK) cell-mediated lysis is determined by the presence of CD18 on A-NK cells and the absence of major histocompatibility complex class I on target cells.
Smits KM; Kuppen PJ; Eggermont AM; Tamatani T; Miyasaka M; Fleuren GJ
Eur J Immunol; 1994 Jan; 24(1):171-5. PubMed ID: 7912675
[TBL] [Abstract][Full Text] [Related]
39. The role of monocytes and natural killer cells in mediating antibody-dependent lysis of colorectal tumour cells.
Abdullah N; Greenman J; Pimenidou A; Topping KP; Monson JR
Cancer Immunol Immunother; 1999 Dec; 48(9):517-24. PubMed ID: 10602889
[TBL] [Abstract][Full Text] [Related]
40. Re-evaluation of the involvement of NK cells and C-type lectin-like NK receptors in modulation of immune responses by multivalent GlcNAc-terminated oligosaccharides.
Grobárová V; Benson V; Rozbeský D; Novák P; Cerný J
Immunol Lett; 2013; 156(1-2):110-7. PubMed ID: 24076118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
